Jazz Pharmaceuticals plc
JAZZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8 | $8 | $10 | $8 |
| - Cash | $2 | $2 | $1 | $1 |
| + Debt | $6 | $6 | $6 | $6 |
| Enterprise Value | $11 | $12 | $15 | $13 |
| Revenue | $4 | $4 | $4 | $3 |
| % Growth | 6.1% | 4.8% | 18.3% | – |
| Gross Profit | $4 | $3 | $3 | $3 |
| % Margin | 89% | 88.6% | 85.2% | 85.8% |
| EBITDA | $2 | $1 | $1 | $1 |
| % Margin | 37.4% | 37.8% | 40.1% | 33.2% |
| Net Income | $1 | $0 | -$0 | -$0 |
| % Margin | 13.8% | 10.8% | -6.1% | -10.6% |
| EPS Diluted | 8.65 | 6.1 | -3.58 | -5.51 |
| % Growth | 41.8% | 270.4% | 35% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | $1 | $1 |